These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of methoxsalen photochemotherapy on cost of treatment for psoriasis. An example of technological assessment. Stern RS; Thibodeau LA; Kleinerman RA; Parrish JA; Fitzpatrick TB; Bleich HL JAMA; 1981 May; 245(19):1913-8. PubMed ID: 7230382 [TBL] [Abstract][Full Text] [Related]
4. PUVA: how to use it for maintenance. Fischer T Semin Dermatol; 1992 Dec; 11(4):287-90. PubMed ID: 1493092 [TBL] [Abstract][Full Text] [Related]
5. Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis. D'Souza LS; Payette MJ J Am Acad Dermatol; 2015 Apr; 72(4):589-98. PubMed ID: 25631851 [TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness analysis comparing methotrexate with PUVA therapy for moderate-severe psoriasis in the sanitary area of Badajoz]. de Argila D; Rodríguez-Nevado I; Chaves A Actas Dermosifiliogr; 2007; 98(1):35-41. PubMed ID: 17374331 [TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical and cost-effectiveness of psoralen + ultraviolet A versus psoralen + sunlight in the treatment of chronic plaque psoriasis in a developing economy. Aggarwal K; Khandpur S; Khanna N; Sharma VK; Pandav CS Int J Dermatol; 2013 Apr; 52(4):478-85. PubMed ID: 23431966 [TBL] [Abstract][Full Text] [Related]
9. [Usefulness and necessity of unsynchronized photosolotherapy and bath-PUVA--two variants of balneophototherapy--in funded ambulatory health care]. Gawlik C; Gibis B; Sander G; Rheinberger P Z Arztl Fortbild Qualitatssich; 2001 Jul; 95(7):509-12. PubMed ID: 11512224 [TBL] [Abstract][Full Text] [Related]
10. Psoriasis treatment and a day-care centre: clinical aspects and an attempt at a cost-benefit analysis. Larkö O; Swanbeck G Acta Derm Venereol; 1982; 62(5):413-8. PubMed ID: 6183891 [TBL] [Abstract][Full Text] [Related]
11. [Combined use of hemosorption and PUVA therapy in the treatment of patients with psoriasis]. Korotkiĭ NG; Gast V; Bart I; Sergienko VI; Potapenko AIa Vestn Dermatol Venerol; 1983 Dec; (12):41-5. PubMed ID: 6673409 [No Abstract] [Full Text] [Related]
12. [Persistent psoriasis: failure of PUVA and peritoneal dialysis-response to methotrexate and hydroxyurea]. de Bast C; Oleffe J; De Coninck A; Van Opdenbosch L Dermatologica; 1982 Nov; 165(5):450-3. PubMed ID: 7169117 [No Abstract] [Full Text] [Related]
13. [Antinuclear antibodies and PUVA therapy]. Cattaneo R; Pancera C; Fenini MG; Gavazzoni R; De Costanza F G Ital Dermatol Venereol; 1982; 117(4):207-10. PubMed ID: 6985322 [No Abstract] [Full Text] [Related]
14. Long-term continuation of psoralen and ultraviolet-A treatment of psoriasis. Stern RS; Melski JW Arch Dermatol; 1982 Jun; 118(6):400-3. PubMed ID: 7092250 [TBL] [Abstract][Full Text] [Related]
15. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions. Trott J; Gerber W; Hammes S; Ockenfels HM Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590 [TBL] [Abstract][Full Text] [Related]